公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2015 | Anti-androgen enzalutamide enhances prostate cancer neuroendocrine (NE) differentiation via altering the infiltrated mast cells → androgen receptor (AR) → miRNA32 signals | Dang Q.; Li L.; Xie H.; He D.; Chen J.; Song W.; Chang L.S.; HONG-CHIANG CHANG ; Yeh S.; Chang C. | Molecular Oncology | 45 | 38 | |
2016 | Correction: Infiltrated pre-adipocytes increase prostate cancer metastasis via modulation of the miR-301a/androgen receptor (AR)/TGF-β1/Smad/MMP9 signals [Oncotarget. 6, 14, (2015) (12326-12339)] doi: 10.18632/oncotarget.3619. | Xie H.; Li L.; Zhu G.; Dang Q.; Ma Z.; He D.; Chang L.; Song W.; HONG-CHIANG CHANG ; Krolewski J.J.; Nastiuk K.L.; Yeh S.; Chang C. | Oncotarget | 6 | 6 | |
2015 | Infiltrated pre-adipocytes increase prostate cancer metastasis via modulation of the miR-301a/androgen receptor (AR)/ TGF-β1/Smad/MMP9 signals | Xie H.; Li L.; Zhu G.; Dang Q.; Ma Z.; He D.; Chang L.; Song W.; HONG-CHIANG CHANG ; Krolewski J.J.; Nastiuk K.L.; Yeh S.; Chang C. | Oncotarget | 45 | 41 |